Imagine facing an aortic aneurysm diagnosis at 70 – the fear of open-chest surgery, long hospital stays, and uncertain recovery. Today, that scenario is rapidly changing. Thanks to advanced endovascular aneurysm repair (EVAR) and thoracic EVAR (TEVAR), patients worldwide are experiencing minimally invasive fixes through small incisions, shorter recoveries, and dramatically improved...

NEWARK, DE — The global intraosseous infusion devices market is entering a steady growth phase, projected to expand from USD 5,446.2 million in 2026 to USD 11,248.6 million by 2036, registering a CAGR of 7.5%, according to Future Market Insights (FMI). The market growth is being fueled by the rising demand for rapid vascular access in emergency and critical care settings, increasing...

NEWARK, DE —The global laparoscopic devices market is projected to grow steadily from USD 15,281.2 million in 2026 to USD 27,756.1 million by 2036, expanding at a compound annual growth rate (CAGR) of 6.1%. This sustained expansion reflects the ongoing shift toward minimally invasive surgery across high-volume specialties, where shorter hospital stays, reduced wound burden, and...

NEWARK, DE | The lung cancer therapeutics market is projected to reach USD 46.8 billion in 2026, driven by a rising cancer burden and accelerating adoption of precision medicine in oncology. According to projections, the market is expected to expand at a CAGR of 11.8% from 2026 to 2036, reaching USD 142.3 billion by the end of the forecast period. This growth reflects higher oncology...

NEWARK, DE | The mosquito-borne infections testing market was valued at USD 1.3 billion in 2025. According to Future Market Insights analysis, the market is estimated to reach USD 1.4 billion in 2026 and expand to USD 2.1 billion by 2036, reflecting a steady compound annual growth rate (CAGR) of 4.7% over the forecast period. This incremental expansion of USD 0.8 billion in...

NEWARK, DE | The patient monitoring system market was valued at USD 62.6 million in 2025. According to Future Market Insights (FMI), the global patient monitoring system market is projected to expand from USD 69.2 million in 2026 to USD 169.9 million by 2036, reflecting a steady compound annual growth rate (CAGR) of 9.4%. This structural expansion, delivering an absolute...

NEWARK, DE | The solid oral dosage PROTAC degrader formulations market was valued at USD 130 million in 2025 and is projected to reach USD 3.49 billion by 2036, expanding at a robust CAGR of 35.40%. With sales expected to reach USD 170 million in 2026, the market is gaining traction as biopharmaceutical innovators shift toward oral delivery formats for targeted protein...